
GBS GBS
Quarterly report 2025-Q3
added 11-12-2025
GBS Total Current Liabilities 2011-2025 | GBS
Annual Total Current Liabilities GBS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.35 M | 5.45 M | 5.88 M | 4.66 M | 3.68 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.88 M | 3.68 M | 5.01 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
129 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.79 | -1.81 % | $ 131 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
468 M | $ 306.68 | -0.46 % | $ 8.65 B | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 45.79 | 1.46 % | $ 6.82 K | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
14.2 B | $ 128.4 | 2.33 % | $ 223 B | ||
|
Boston Scientific Corporation
BSX
|
6.4 B | $ 92.01 | -0.6 % | $ 135 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.16 | 9.55 % | $ 118 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
219 M | $ 9.59 | -2.74 % | $ 689 M | ||
|
InMode Ltd.
INMD
|
69.9 M | $ 14.36 | -1.03 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 0.98 | 5.89 % | $ 15.8 M | ||
|
IRadimed Corporation
IRMD
|
8.51 M | $ 96.66 | 0.44 % | $ 1.22 B | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.04 B | $ 163.43 | -1.21 % | $ 12.2 B | ||
|
Accuray Incorporated
ARAY
|
193 M | $ 1.05 | -0.94 % | $ 108 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
10.4 M | $ 12.55 | -1.3 % | $ 339 M | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 14.83 | 0.54 % | $ 97.2 M | ||
|
AxoGen
AXGN
|
30.6 M | $ 29.82 | -1.88 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
278 M | $ 40.28 | -1.33 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
392 M | $ 62.88 | 0.21 % | $ 3.41 B | ||
|
OrthoPediatrics Corp.
KIDS
|
34 M | $ 17.67 | 0.4 % | $ 408 M | ||
|
Globus Medical
GMED
|
856 M | $ 86.48 | -0.24 % | $ 11.7 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 13.54 | 0.86 % | $ 1.04 B | ||
|
LENSAR
LNSR
|
15 M | $ 11.6 | 0.78 % | $ 134 M | ||
|
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
153 M | $ 19.95 | -0.08 % | $ 2.85 B | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 3.15 | -7.35 % | $ 4.92 M | ||
|
Establishment Labs Holdings
ESTA
|
68.3 M | $ 72.06 | -0.63 % | $ 2.03 B |